Quality of life in classical homocystinuria
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study surveys how classical homocystinuria (CBS deficiency) affects daily life and well-being. It includes patients age 8 and up, parents of younger or cognitively impaired children, and medical experts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child have CBS deficiency (also called classical homocystinuria)
- You are at least 8 years old, OR you are a parent of a young child or a child with cognitive challenges, OR you are a medical expert on this condition
- You can understand and agree to the study in German or English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new enzyme replacement therapy called pegtibatinase for children with classical homocystinuria (HCU). The enzyme helps break down homocysteine, which may lower its levels in the blood and reduce symptoms.
This trial tests an injectable drug called pegtibatinase for people with a rare condition called homocystinuria. It aims to lower high levels of homocysteine in the blood compared to a placebo, while you continue your usual treatments.
This study looks at how cysteamine affects the bone health of people with nephropathic cystinosis, a rare genetic condition. It includes children and adults who are already taking cysteamine by mouth and will follow the study plan closely.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
This study looks at parenting in adults with congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency. It aims to understand how the condition affects family life so doctors can offer better support.
This study looks at how Fabry disease affects daily life in adults who haven't started treatment yet. Researchers want to understand your experiences and challenges to improve care for people with this rare genetic condition.
Hear when a new Homocystinuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.